JP2012512858A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512858A5
JP2012512858A5 JP2011541582A JP2011541582A JP2012512858A5 JP 2012512858 A5 JP2012512858 A5 JP 2012512858A5 JP 2011541582 A JP2011541582 A JP 2011541582A JP 2011541582 A JP2011541582 A JP 2011541582A JP 2012512858 A5 JP2012512858 A5 JP 2012512858A5
Authority
JP
Japan
Prior art keywords
group
poly
molecule
glycan
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011541582A
Other languages
English (en)
Japanese (ja)
Other versions
JP5877712B2 (ja
JP2012512858A (ja
Filing date
Publication date
Priority claimed from GBGB0823309.0A external-priority patent/GB0823309D0/en
Application filed filed Critical
Publication of JP2012512858A publication Critical patent/JP2012512858A/ja
Publication of JP2012512858A5 publication Critical patent/JP2012512858A5/ja
Application granted granted Critical
Publication of JP5877712B2 publication Critical patent/JP5877712B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011541582A 2008-12-19 2009-12-21 官能基化試薬およびその使用 Active JP5877712B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13901408P 2008-12-19 2008-12-19
US61/139,014 2008-12-19
GBGB0823309.0A GB0823309D0 (en) 2008-12-19 2008-12-19 Functionalising reagents and their uses
GB0823309.0 2008-12-19
PCT/GB2009/002924 WO2010070300A2 (en) 2008-12-19 2009-12-21 Functionalising reagents and their uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015137984A Division JP6240122B2 (ja) 2008-12-19 2015-07-09 官能基化試薬およびその使用

Publications (3)

Publication Number Publication Date
JP2012512858A JP2012512858A (ja) 2012-06-07
JP2012512858A5 true JP2012512858A5 (https=) 2013-02-07
JP5877712B2 JP5877712B2 (ja) 2016-03-08

Family

ID=40343997

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011541582A Active JP5877712B2 (ja) 2008-12-19 2009-12-21 官能基化試薬およびその使用
JP2015137984A Active JP6240122B2 (ja) 2008-12-19 2015-07-09 官能基化試薬およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015137984A Active JP6240122B2 (ja) 2008-12-19 2015-07-09 官能基化試薬およびその使用

Country Status (8)

Country Link
US (2) US8785595B2 (https=)
EP (2) EP2886132B1 (https=)
JP (2) JP5877712B2 (https=)
CN (2) CN104558098B (https=)
ES (2) ES2556328T3 (https=)
GB (1) GB0823309D0 (https=)
PL (2) PL2886132T3 (https=)
WO (1) WO2010070300A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0823309D0 (en) 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
US9534008B2 (en) 2011-08-08 2017-01-03 California Institute Of Technology Small molecule compounds that control plant- and insect-pathogenic nematodes
WO2013022985A2 (en) 2011-08-08 2013-02-14 Boyce Thompson Institute For Plant Research Small molecule compounds for the control of nematodes
EP2907823A1 (en) * 2014-02-14 2015-08-19 Gene Signal International SA Polypeptide fragments of 168A-T2 and compositions comprising them for use in treating cancer
GB201419108D0 (en) * 2014-10-27 2014-12-10 Glythera Ltd Materials and methods relating to linkers for use in antibody drug conjugates
ES3062420T3 (en) 2016-08-25 2026-04-10 California Inst Of Techn Ascaroside treatment of eosinophilic esophagitis
WO2020025108A1 (en) 2018-07-31 2020-02-06 Astrazeneca Ab Linkers and conjugates
CN114423774B (zh) 2019-05-17 2024-11-08 加利福尼亚技术学院 蛔苷衍生物和使用方法
CN115998707A (zh) * 2021-10-21 2023-04-25 福州大学 一种聚二硫多肽纳米粒及其制备方法和多肽药物口服制剂
CN115181091A (zh) * 2022-06-21 2022-10-14 江苏联环药业股份有限公司 一种贝他斯汀的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4719272A (en) * 1984-06-27 1988-01-12 National Starch And Chemical Corporation Monomeric cationic glycoside derivatives
CA1236454A (en) * 1984-06-27 1988-05-10 John J. Tsai Monomeric cationic glycoside derivatives
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH01502118A (ja) * 1987-01-15 1989-07-27 セルテク・リミテツド チオール反応性架橋剤
DE3942355A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfuer geeignetes diagnostisches mittel
DK0575545T3 (da) * 1991-03-15 2003-09-15 Amgen Inc Pegylering af polypeptider
ATE199392T1 (de) 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US6309646B1 (en) * 1996-05-09 2001-10-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
WO2001062827A2 (en) * 2000-02-22 2001-08-30 Shearwater Corporation N-maleimidyl polymer derivatives
US20030096281A1 (en) 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
US20040214228A9 (en) 2001-09-14 2004-10-28 Ganesh Venkataraman Methods of evaluating glycomolecules for enhanced activities
EE05509B1 (et) * 2002-01-18 2012-02-15 Biogen@Idec@Ma@Inc Aktiveeritud polalkleenglkoolpolmeer ja seda sisaldavad kompositsioonid
NZ540490A (en) * 2002-09-09 2007-10-26 Nektar Therapeutics Al Corp Water-soluble polymer alkanal conjugates with human growth hormone
JP2004262781A (ja) * 2003-02-28 2004-09-24 Noguchi Inst 蛍光糖鎖プローブ
US20050074895A1 (en) 2003-09-05 2005-04-07 Bio-Rad Laboratories, Inc. Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins
CN101223137A (zh) * 2005-07-11 2008-07-16 默克公司 制备氢化异二氢吲哚速激肽受体拮抗剂的方法
GB0823309D0 (en) 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Similar Documents

Publication Publication Date Title
JP2012512858A5 (https=)
AU2023200440B2 (en) Antagonistic anti-tumor necrosis factor receptor superfamily antibodies
AU2020322193B2 (en) Heterotandem bicyclic peptide complexes
Gaertner et al. Site-specific attachment of functionalized poly (ethylene glycol) to the amino terminus of proteins
CN102317305B (zh) 硫醇基官能化试剂及其用途
EP1955712A1 (en) Multimeric conjugate
CN111902429A (zh) 多聚体双环肽配体
ATE486090T1 (de) Erfindung betreffend glp-1 und exendin
CN104736567A (zh) 阿立哌唑半抗原的抗体及其用途
JP2009284902A5 (https=)
RU2017103462A (ru) Материалы и способы, связанные с линкерами для применения в конъюгатах лекарственного средства и белка
JP2023510972A (ja) 抗st2抗体及びその適用
CN103476798A (zh) 在粘合物质和可铁宁的粘合体上结合有抗-可铁宁抗体的复合体及其用途
CN107174838B (zh) 一种含锆金属有机骨架材料修饰的开管毛细管柱及其应用
JP2020500186A5 (https=)
JP2020532565A5 (https=)
CN109661407A (zh) 融合蛋白构建体
CN103601662B (zh) 一种褪黑素半抗原、褪黑素完全抗原及其制备方法和应用
CN116891454B (zh) 小分子抑制剂及制备方法与其在制备抗癌药物中的应用
CY1126762T1 (el) Διαδικασια για τη συμπυκνωση αντισωματων και θεραπευτικων προϊοντων αυτων
WO2025248090A1 (en) Novel brd4 binders
Picha et al. Engineering peptide therapeutics using MIMETIBODY™ technology
BRPI1004360A2 (pt) Desenvolvimento de processo de obtenção de peguilado de albumina humana (hsba)
CN104628668A (zh) 一种医药中间体噁二唑类化合物的合成方法
CN112004535A (zh) 用于癌症疗法的包括hdac抑制剂和cd137激动剂的组合